Product Information
VYLIBRA 28 TABLET is a generic product labeled by Afaxys Pharma, LLC, priced at $0.1257 per EA under NDC 50102023511. Its NADAC has been published 425 times since May 9, 2018.
Manufacturer
Afaxys Pharma, LLCNDC
50102023511
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205449On Market Since
7/7/2016
Price Statistics
The NADAC for VYLIBRA 28 TABLET has been published 425 times since May 9, 2018, and over the history we have for it it has declined 53.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1257 per EA |
|---|---|
| All-time high | $0.2724 (May 16, 2018) |
| All-time low | $0.1011 (Nov 20, 2024) |
| 52-week high | $0.1351 |
| 52-week low | $0.1230 |
| Median price | $0.1673 |
| Average price | $0.1792 |
| Largest weekly change | -21.9% (Nov 20, 2024) |
| Weeks tracked | 425 |
| Tracking since | May 9, 2018 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VYLIBRA 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VYLIBRA 28 TABLET, manufactured by Afaxys Pharma, LLC, is $0.1257 per EA (NDC 50102023511), effective Jun 24, 2026.
How has the price of VYLIBRA 28 TABLET changed over time?
Over the history we have for it, the NADAC for VYLIBRA 28 TABLET has declined 53.8%. It has been tracked across 425 weekly CMS publications since May 9, 2018.
What are the highest and lowest recorded NADAC prices for VYLIBRA 28 TABLET?
Since May 9, 2018, the NADAC for VYLIBRA 28 TABLET has ranged from a low of $0.1011 (Nov 20, 2024) to a high of $0.2724 (May 16, 2018), with a median of $0.1673 per EA.
Are there cheaper alternatives to VYLIBRA 28 TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TRI-LO-ESTARYLLA TABLET, is $0.1049 per EA — about 17% below VYLIBRA 28 TABLET.
Who manufactures VYLIBRA 28 TABLET?
VYLIBRA 28 TABLET (NDC 50102023511) is labeled by Afaxys Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification